395 related articles for article (PubMed ID: 28325523)
1. Total management of chronic obstructive pulmonary disease (COPD) as an independent risk factor for cardiovascular disease.
Onishi K
J Cardiol; 2017 Aug; 70(2):128-134. PubMed ID: 28325523
[TBL] [Abstract][Full Text] [Related]
2. Does Cardiovascular Comorbidity Influence the Prescribing of Bronchodilators in Chronic Obstructive Pulmonary Disease?
Adesanoye DT; Willey CJ
Ann Pharmacother; 2017 Oct; 51(10):855-861. PubMed ID: 28573879
[TBL] [Abstract][Full Text] [Related]
3. Strategies for reducing the risk of cardiovascular disease in patients with chronic obstructive pulmonary disease.
Ferri C
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):103-11. PubMed ID: 25655487
[TBL] [Abstract][Full Text] [Related]
4. Outcomes in patients hospitalized for heart failure and chronic obstructive pulmonary disease: differences in clinical profile and treatment between 2002 and 2009.
Staszewsky L; Cortesi L; Tettamanti M; Dal Bo GA; Fortino I; Bortolotti A; Merlino L; Latini R; Roncaglioni MC; Baviera M
Eur J Heart Fail; 2016 Jul; 18(7):840-8. PubMed ID: 27098360
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease.
Canepa M; Franssen FME; Olschewski H; Lainscak M; Böhm M; Tavazzi L; Rosenkranz S
JACC Heart Fail; 2019 Oct; 7(10):823-833. PubMed ID: 31521680
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and management of COPD and heart failure comorbidity in the general practitioner setting.
Pirina P; Martinetti M; Spada C; Zinellu E; Pes R; Chessa E; Fois AG; Miravitlles M;
Respir Med; 2017 Oct; 131():1-5. PubMed ID: 28947013
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease.
Petta V; Perlikos F; Loukides S; Bakakos P; Chalkias A; Iacovidou N; Xanthos T; Tsekoura D; Hillas G
Heart Fail Rev; 2017 Nov; 22(6):753-763. PubMed ID: 28840400
[TBL] [Abstract][Full Text] [Related]
8. The association between COPD and heart failure risk: a review.
de Miguel Díez J; Chancafe Morgan J; Jiménez García R
Int J Chron Obstruct Pulmon Dis; 2013; 8():305-12. PubMed ID: 23847414
[TBL] [Abstract][Full Text] [Related]
9. Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease.
Campo G; Pavasini R; Biscaglia S; Contoli M; Ceconi C
Eur Heart J Cardiovasc Pharmacother; 2015 Jul; 1(3):205-11. PubMed ID: 27533997
[TBL] [Abstract][Full Text] [Related]
10. [Chronic obstructive pulmonary disease and cardiovascular diseases--'cardiopulmonary continuum'].
Batura-Gabryel H; Grabicki M
Pneumonol Alergol Pol; 2014; 82(6):590-6. PubMed ID: 25339571
[TBL] [Abstract][Full Text] [Related]
11. Treatment of COPD and COPD-heart failure comorbidity in primary care in different stages of the disease.
Pirina P; Zinellu E; Martinetti M; Spada C; Piras B; Collu C; Fois AG;
Prim Health Care Res Dev; 2020 Jun; 21():e16. PubMed ID: 32498750
[TBL] [Abstract][Full Text] [Related]
12. Heart failure and chronic obstructive pulmonary disease: a review.
Horodinschi RN; Bratu OG; Dediu GN; Pantea Stoian A; Motofei I; Diaconu CC
Acta Cardiol; 2020 Apr; 75(2):97-104. PubMed ID: 30650022
[TBL] [Abstract][Full Text] [Related]
13. Challenges in the Management of Patients with Chronic Obstructive Pulmonary Disease and Heart Failure With Reduced Ejection Fraction.
Jaiswal A; Chichra A; Nguyen VQ; Gadiraju TV; Le Jemtel TH
Curr Heart Fail Rep; 2016 Feb; 13(1):30-6. PubMed ID: 26780914
[TBL] [Abstract][Full Text] [Related]
14. Bronchodilators in heart failure patients with COPD: is it time for a clinical trial?
Mentz RJ; Fiuzat M; Kraft M; Lindenfeld J; O'Connor CM
J Card Fail; 2012 May; 18(5):413-22. PubMed ID: 22555273
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease and COPD: dangerous liaisons?
Rabe KF; Hurst JR; Suissa S
Eur Respir Rev; 2018 Sep; 27(149):. PubMed ID: 30282634
[TBL] [Abstract][Full Text] [Related]
16. [Chronic obstructive pulmonary disease and cardiovascular system].
Gürgün A; Gürgün C
Tuberk Toraks; 2008; 56(4):464-71. PubMed ID: 19123087
[TBL] [Abstract][Full Text] [Related]
17. Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry.
Canepa M; Straburzynska-Migaj E; Drozdz J; Fernandez-Vivancos C; Pinilla JMG; Nyolczas N; Temporelli PL; Mebazaa A; Lainscak M; Laroche C; Maggioni AP; Piepoli MF; Coats AJS; Ferrari R; Tavazzi L;
Eur J Heart Fail; 2018 Jan; 20(1):100-110. PubMed ID: 28949063
[TBL] [Abstract][Full Text] [Related]
18. Right Heart Failure as a Risk for Stroke in Patients with Chronic Obstructive Pulmonary Disease: A Case-Control Study.
Orea-Tejeda A; Bozada-Gutiérrez K; Pineda-Juárez J; González-Islas D; Santellano-Juárez B; Keirns-Davies C; Peláez-Hernández V; Hernández-Zenteno R; Sánchez-Santillán R; Cintora-Martínez C
J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2988-2993. PubMed ID: 28844547
[TBL] [Abstract][Full Text] [Related]
19. Comorbidities of chronic obstructive pulmonary disease.
Corsonello A; Antonelli Incalzi R; Pistelli R; Pedone C; Bustacchini S; Lattanzio F
Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S21-8. PubMed ID: 22209926
[TBL] [Abstract][Full Text] [Related]
20. Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD.
Huang YL; Lai CC; Wang YH; Wang CY; Wang JY; Wang HC; Yu CJ; Chen L
Int J Chron Obstruct Pulmon Dis; 2017; 12():2987-2996. PubMed ID: 29066880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
